Page last updated: 2024-10-31

milrinone and Critical Illness

milrinone has been researched along with Critical Illness in 10 studies

Critical Illness: A disease or state in which death is possible or imminent.

Research Excerpts

ExcerptRelevanceReference
"Treatment with the PDE-III inhibitor milrinone improves hemodynamics in patients with heart failure."9.09Milrinone therapy in catecholamine-dependent critically ill patients with heart failure. ( Delle-Karth, G; Haumer, M; Heinz, G; Koller-Strametz, J; Koreny, M; Siostrzonek, P, 2000)
"Treatment with the PDE-III inhibitor milrinone improves hemodynamics in patients with heart failure."5.09Milrinone therapy in catecholamine-dependent critically ill patients with heart failure. ( Delle-Karth, G; Haumer, M; Heinz, G; Koller-Strametz, J; Koreny, M; Siostrzonek, P, 2000)
"Milrinone is a drug frequently used for hemodynamic support in children during critical illness."5.05The effect of milrinone on hemodynamic and gas exchange parameters in children. ( Dorsey, V; Flores, S; Loomba, RS; Villarreal, EG, 2020)
" We hypothesized that milrinone administration would increase cardiac index (CI) and oxygen delivery (Do2) in ICU patients, and that a pharmacokinetic model previously developed in cardiac surgery patients may be used to predict milrinone plasma concentrations in a medical-surgical ICU population."2.68Pharmacodynamics and pharmacokinetics of milrinone administration to increase oxygen delivery in critically ill patients. ( Butterworth, JF; Coursin, DB; Levy, JH; MacGregor, DA; Meredith, JW; Prielipp, RC; Wood, KE, 1996)
"Milrinone is an inotropic drug used in a variety of clinical settings in adults and children."2.53Milrinone Dosing Issues in Critically Ill Children With Kidney Injury: A Review. ( Gist, KM; Goldstein, SL; Joy, MS; Vinks, AA, 2016)
"Milrinone is an inotrope widely used for treatment of cardiac failure."2.53Milrinone for cardiac dysfunction in critically ill adult patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis. ( Bekema, HJ; Gluud, C; Keus, F; Koster, G; van der Horst, IC; Wetterslev, J, 2016)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (20.00)18.2507
2000's1 (10.00)29.6817
2010's6 (60.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Loomba, RS1
Dorsey, V1
Villarreal, EG1
Flores, S1
Schindler, E1
Yamamoto, T1
Panchal, AK1
Manzi, J1
Connolly, S1
Christensen, M1
Wakeham, M1
Goday, PS1
Mikhailov, TA1
McNeilly, RG1
Greco, T1
CalabrĂ², MG1
Covello, RD1
Greco, M1
Pasin, L1
Morelli, A1
Landoni, G1
Zangrillo, A1
Gist, KM1
Goldstein, SL1
Joy, MS1
Vinks, AA1
Koster, G1
Bekema, HJ1
Wetterslev, J1
Gluud, C1
Keus, F1
van der Horst, IC1
Lindeborg, DM1
Pearl, RG1
Prielipp, RC1
MacGregor, DA1
Butterworth, JF1
Meredith, JW1
Levy, JH1
Wood, KE1
Coursin, DB1
Siostrzonek, P1
Koreny, M1
Delle-Karth, G1
Haumer, M1
Koller-Strametz, J1
Heinz, G1

Reviews

5 reviews available for milrinone and Critical Illness

ArticleYear
The effect of milrinone on hemodynamic and gas exchange parameters in children.
    Cardiology in the young, 2020, Volume: 30, Issue:1

    Topics: Blood Gas Analysis; Cardiac Output, Low; Cardiotonic Agents; Child; Critical Illness; Hemodynamics;

2020
A Bayesian network meta-analysis on the effect of inodilatory agents on mortality.
    British journal of anaesthesia, 2015, Volume: 114, Issue:5

    Topics: Bayes Theorem; Cardiac Surgical Procedures; Critical Illness; Dobutamine; Enoximone; Humans; Hydrazo

2015
Milrinone Dosing Issues in Critically Ill Children With Kidney Injury: A Review.
    Journal of cardiovascular pharmacology, 2016, Volume: 67, Issue:2

    Topics: Acute Kidney Injury; Child; Critical Illness; Dose-Response Relationship, Drug; Humans; Metabolic Cl

2016
Milrinone for cardiac dysfunction in critically ill adult patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis.
    Intensive care medicine, 2016, Volume: 42, Issue:9

    Topics: Adult; Critical Illness; Heart Diseases; Humans; Milrinone; Phosphodiesterase 3 Inhibitors; Randomiz

2016
Inotropic therapy in the critically ill patient.
    International anesthesiology clinics, 1993,Spring, Volume: 31, Issue:2

    Topics: Amrinone; Cardiac Glycosides; Cardiotonic Agents; Catecholamines; Critical Illness; Enoximone; Human

1993

Trials

2 trials available for milrinone and Critical Illness

ArticleYear
Pharmacodynamics and pharmacokinetics of milrinone administration to increase oxygen delivery in critically ill patients.
    Chest, 1996, Volume: 109, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Cardiac Output; Critical Illness; Female; Hemodynamics; Humans; Male

1996
Milrinone therapy in catecholamine-dependent critically ill patients with heart failure.
    Acta anaesthesiologica Scandinavica, 2000, Volume: 44, Issue:4

    Topics: Aged; Cardiotonic Agents; Catecholamines; Critical Illness; Dobutamine; Drug Therapy, Combination; F

2000

Other Studies

3 other studies available for milrinone and Critical Illness

ArticleYear
New Drugs for Old Problems: Which Inotropes for Critically Ill Children?
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2018, Volume: 19, Issue:7

    Topics: Cardiac Output, Low; Child; Critical Illness; Dobutamine; Double-Blind Method; Humans; Milrinone; Pi

2018
Safety of Enteral Feedings in Critically Ill Children Receiving Vasoactive Agents.
    JPEN. Journal of parenteral and enteral nutrition, 2016, Volume: 40, Issue:2

    Topics: Adolescent; Cardiovascular Agents; Child; Child, Preschool; Critical Illness; Dobutamine; Dopamine;

2016
Sepsis, venous return, and teleology.
    Medical hypotheses, 2014, Volume: 83, Issue:5

    Topics: Algorithms; Blood Pressure; Cardiac Output; Coronary Circulation; Critical Illness; Dihydroergotamin

2014